norfloxacin has been researched along with metronidazole in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 3 (11.54) | 29.6817 |
| 2010's | 14 (53.85) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ; Teraiya, SB | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Alamry, KA; Birs, AS; Gonzalez, CF; Ibrahim, MA; Katritzky, AR; Panda, SS; Serrano, JC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Gao, WW; Gopala, L; Li, ZZ; Tangadanchu, VKR; Zhou, CH | 1 |
| Ba, Y; Hou, X; Wang, S; Xu, Z; Yang, H; Zhang, J | 1 |
| Beteck, RM; Jesumoroti, OJ; Legoabe, LJ; Patel, OPS | 1 |
| Ansari, MF; Li, S; Sun, H; Tan, YM; Zhou, CH | 1 |
| Shen, XJ; Wu, FY; Yang, JG | 1 |
| Edlund, C; Lahnborg, G; Nord, CE | 1 |
| Dassiou, M; Maraki, S; Margioris, AN; Samonis, G; Toloudis, P; Tselentis, Y | 1 |
| Glück, T; Schölmerich, J | 1 |
| Pandya, S | 1 |
| Basheer, M; Pandey, S; Roy, S; Udupa, N | 1 |
| Cohen, CR; Gatei, W; Meier, AS; Muyodi, J; Mwachari, CW; Waiyaki, P | 1 |
| Dupuis, RE; Heinzen, EL; Johnson, MW; Naderer, OJ; Smith, PC; Wiwattanawongsa, K | 1 |
| Rajendran, R; Sreekumar, S; Sudhakar, A | 1 |
| Geng, RX; Kumar, KV; Zhang, L; Zhou, CH | 1 |
| Battini, N; Hu, YY; Yadav Bheemanaboina, RR; Zhou, CH | 1 |
| Bhagatwala, J; Rao, SSC | 1 |
| Patel, PR; Prajapati, PB; Shah, SA | 1 |
5 review(s) available for norfloxacin and metronidazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
Topics: Anti-Bacterial Agents; Bacterial Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles | 2019 |
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiprotozoal Agents; Drug Development; Humans; Hypoglycemic Agents; Metronidazole | 2021 |
[Spontaneous bacterial peritonitis].
Topics: Animals; Ascites; Bacterial Infections; Bacterial Translocation; Cefotaxime; Diagnosis, Differential; Drug Therapy, Combination; Humans; Intestine, Small; Liver Cirrhosis; Metronidazole; Norfloxacin; Peritonitis; Prognosis; Risk Factors | 1998 |
Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management.
Topics: Age Factors; Anti-Bacterial Agents; Bacteria; Blind Loop Syndrome; Breath Tests; Clinical Trials as Topic; Colectomy; Female; Food, Formulated; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Intestine, Small; Male; Metronidazole; Microbiological Techniques; Norfloxacin; Prevalence; Probiotics; Proton Pump Inhibitors; Rifaximin; Risk Factors; Sex Factors; Treatment Outcome | 2019 |
1 trial(s) available for norfloxacin and metronidazole
| Article | Year |
|---|---|
The influence of norfloxacin and metronidazole on the disposition of mycophenolate mofetil.
Topics: Administration, Oral; Adult; Area Under Curve; Drug Therapy, Combination; Female; Humans; Male; Metabolic Clearance Rate; Metronidazole; Mycophenolic Acid; Norfloxacin; Time Factors | 2005 |
20 other study(ies) available for norfloxacin and metronidazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
An efficient one-pot synthesis, structure, antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones.
Topics: Anti-Infective Agents; Antioxidants; Azepines; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Quinolines | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and antibacterial evaluation of amino acid-antibiotic conjugates.
Topics: Amino Acids; Anti-Bacterial Agents; Bacillus subtilis; Dose-Response Relationship, Drug; Escherichia coli; Metronidazole; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Sulfadiazine | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Discovery of novel nitroimidazole enols as Pseudomonas aeruginosa DNA cleavage agents.
Topics: Albumins; Anti-Bacterial Agents; DNA Cleavage; DNA Replication; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Discovery; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles; Pseudomonas aeruginosa; Quantum Theory; Structure-Activity Relationship | 2017 |
Unique iminotetrahydroberberine-corbelled metronidazoles as potential membrane active broad-spectrum antibacterial agents.
Topics: Anti-Bacterial Agents; Berberine; Metronidazole; Microbial Sensitivity Tests; Norfloxacin; Oximes; Penicillin-Binding Proteins; Pseudomonas aeruginosa | 2022 |
[Quinolones in the treatment of acute amebic dysentery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Dysentery, Amebic; Female; Humans; Infant; Male; Metronidazole; Middle Aged; Norfloxacin; Pipemidic Acid; Quinolones | 1991 |
The efficacy of pefloxacin in comparison to gentamicin in the treatment of experimentally induced peritonitis in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Clostridium perfringens; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Male; Metronidazole; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Peritonitis; Proteus mirabilis; Rats; Rats, Inbred Strains | 1986 |
Murine yeast gut flora affected by tetracycline, metronidazole and norfloxacin.
Topics: Administration, Oral; Animals; Candida albicans; Digestive System; Feces; Male; Metronidazole; Mice; Mice, Inbred ICR; Norfloxacin; Tetracycline | 1994 |
Fixed drug combination of treatment of diarrhea.
Topics: Anti-Infective Agents; Child; Child, Preschool; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infant; Metronidazole; Norfloxacin | 1998 |
Development and evaluation of transdermal formulations containing metronidazole and norfloxacin for the treatment of burn wound.
Topics: Administration, Cutaneous; Animals; Burns; Male; Metronidazole; Norfloxacin; Rats; Rats, Wistar | 1999 |
Chronic diarrhoea in HIV-1-infected adults in Nairobi, Kenya: evaluation of risk factors and the WHO treatment algorithm.
Topics: Adult; Algorithms; Anti-Infective Agents; Chronic Disease; Cohort Studies; Diarrhea; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Kenya; Loperamide; Metronidazole; Norfloxacin; Risk Factors | 2003 |
Biodegradable tocopherol acetate as a drug carrier to prevent ureteral stent-associated infection.
Topics: Absorbable Implants; Anti-Infective Agents, Urinary; Bacterial Adhesion; Cross Infection; Drug Carriers; Drug-Eluting Stents; Escherichia coli; Humans; In Vitro Techniques; Materials Testing; Metronidazole; Microbial Sensitivity Tests; Norfloxacin; Prosthesis-Related Infections; Staphylococcus epidermidis; Tocopherols; Ureter; Urinary Tract Infections | 2011 |
Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu(2+) mediated DNA-targeting antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Chemistry Techniques, Synthetic; Ciprofloxacin; Copper; DNA, Bacterial; Drug Evaluation, Preclinical; Fibroblasts; Fluoroquinolones; HEK293 Cells; Humans; Metronidazole; Mice; Microbial Sensitivity Tests; Molecular Targeted Therapy; Norfloxacin; Pseudomonas aeruginosa; Quinolones; Structure-Activity Relationship | 2015 |
Sulfonamide-Derived Four-Component Molecular Hybrids as Novel DNA-Targeting Membrane Active Potentiators against Clinical Escherichia coli.
Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Carbonic Anhydrases; Cell Membrane Permeability; Cell Survival; DNA, Bacterial; Drug Compounding; Drug Resistance, Bacterial; Drug Resistance, Fungal; Drug Therapy, Combination; Escherichia coli; Ethanol; Fluconazole; Humans; Hydrogen Bonding; Isoenzymes; MCF-7 Cells; Metronidazole; Models, Molecular; Molecular Docking Simulation; Norfloxacin; Piperazine; Sulfonamides | 2019 |
Chemometric and DoE-Based Analytical Quality Risk Management to HPTLC Method for Simultaneous Estimation of Metronidazole and Norfloxacin.
Topics: Chemometrics; Chromatography, High Pressure Liquid; Metronidazole; Norfloxacin; Risk Management | 2023 |